TICKERNERD
Menu
VREXVREXHealthcare · Medical Devices

VREX Stock Forecast: Varex Imaging Corp. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$18
−0.05% on the day

The 3 Wall Street analysts covering Varex Imaging Corp. hold a median 12-month price target of $19 — +2.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 12 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$778.1M
Ticker Nerd rank
80 / 100
Median analyst target
$19
Analysts covering
3
Revenue$210.5M+3.7% y/y
Operating income$22.8M
Net income$15.9M
Free cash flow$12.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.3%
1M
−0.6%
YTD
+58.5%
1Y
+60.5%
From 52W high
−0.6%
From 52W low
+98.1%
$9
$19
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

VREX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Varex Imaging Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
80 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
96
Growth
91
Value
77
Issuance
74
Quality
70
Revisions
54
Size
48
Accruals
28
Volatility
16

Momentum (96): The shares have been drifting up relative to others.

Volatility (16): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

VREX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on VREX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$12$14$16$18$20Oct 25Jan 26Apr 26Jul 26VREXHigh $19Median $19Low $19

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
0 Buy3 Hold0 Sell
Low $19Median $19High $19

The green dot is the last close — the median target sits +2.4% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
17 Aug 2026CJS SecuritiesDowngradeMarket Perform—
11 Aug 2026OppenheimerDowngradePerform—
10 Aug 2026Sidoti & Co.DowngradeNeutral$19
19 Nov 2025B. Riley SecuritiesReiteratesBuy—
19 Nov 2025B. Riley SecuritiesReiteratesBuy$16
19 Nov 2025OppenheimerMaintainsOutperform$23 → $18
19 Nov 2025OppenheimerMaintainsOutperform—
8 Aug 2025B. Riley SecuritiesMaintainsBuy—
7 Feb 2025B. Riley SecuritiesReiteratesBuy—
7 Feb 2025OppenheimerMaintainsOutperform—
23 Aug 2024B. Riley SecuritiesInitiatesBuy—
15 Nov 2023OppenheimerMaintainsOutperform—
2 Aug 2023OppenheimerReiteratesOutperform—
24 May 2023JefferiesMaintainsHold—
12 Oct 2022JefferiesInitiatesHold—
5 Feb 2021OppenheimerUpgradeOutperform—
13 Aug 2020OppenheimerDowngradePerform—
13 May 2020JefferiesMaintainsHold—
13 May 2020JP MorganDowngradeNeutral—
13 May 2020Sidoti & Co.MaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. VREX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

VREX vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Varex Imaging Corp. returned +60.5% against +17.5% for the S&P 500, dividends included.

VREX vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160Oct 25Jan 26Apr 26Jul 26VREXS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

VREX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+12.9%
Analysts raising
4
Analysts cutting
0
Fundamentals

Varex Imaging Corp. (VREX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
34.8×

Cheaper than 22% of US stocks

Price / sales
0.9×

Cheaper than 72% of US stocks

Price / book
1.6×

Cheaper than 52% of US stocks

EV / EBITDA
10.8×

Cheaper than 35% of US stocks

Growth & margins
Revenue growth (YoY)
3.7%

Higher than 35% of US stocks

Earnings growth (YoY)
—
Gross margin
36.4%

Higher than 44% of US stocks

Operating margin
10.8%

Higher than 65% of US stocks

Net margin
2.6%

Higher than 54% of US stocks

Returns & dividend
Return on equity
4.6%

Higher than 53% of US stocks

Return on assets
4.2%

Higher than 72% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Varex Imaging Corp. (VREX) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Varex Imaging Corp. has a market value of $778.1M and an enterprise value of $1.1B.

  • Revenue in the twelve months to 30 June 2026: $865.0M. The latest quarter grew 3.7% year on year.

  • Net income over the same four quarters: $22.5M, a 2.6% net margin.

  • Diluted earnings per share, trailing twelve months: $0.52.

  • Free cash flow in the twelve months to 30 June 2026: −$20.2M.

  • Shares outstanding: 42.1M.

  • Trailing P/E: 34.8×; forward P/E: 17.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Varex Imaging Corp. employs 2,500 people — $346K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Sept 2026

Data provided by Twelve Data

Peers

VREX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
VREXVarex Imaging Corp.$778.1M
80
QDELQuidelOrtho Corp.$803.3M
35
SIBNSI-BONE, Inc.$811.8M
74
AVRAnteris Technologies Global Corp.$811.9M
22
BBNXBeta Bionics, Inc.$729.5M
40
AHCOAdaptHealth Corp.$823.6M
43
INMDInMode Ltd.$856.5M
76

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Varex Imaging Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest VREX news & analysis

VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders

Business Wire · 12 Sept 2026negative

Halper Sadeh LLC, an investor rights law firm, announced it is investigating whether Varex Imaging Corporation obtained a fair price for its shareholders in its sale to Teledyne Technologies for $18.90 per share in cash. The firm is encouraging Varex shareholders to learn about their rights and options regarding the transaction.

Why it matters — The investigation raises questions about the fairness of the acquisition price for VREX shareholders and could signal potential legal scrutiny of the sale terms.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan's Famous, Inc. (Nasdaq – NATH)

GlobeNewsWire · 28 Aug 2026neutral

Brodsky & Smith, a law firm, issued a shareholder update reminding investors of investigations involving Varex Imaging Corporation and several other companies, inviting shareholders to contact the firm at no cost to discuss the investigations.

Why it matters — A VREX watcher would want to monitor the investigation as it could relate to potential shareholder concerns regarding the company.

Should Value Investors Buy VAREX IMAGING (VREX) Stock?

Zacks Investment Research · 24 Aug 2026neutral

Zacks Investment Research published an article asking whether value investors should buy Varex Imaging (VREX) stock, explaining that the firm's approach combines its Zacks Rank system with value, growth, and momentum trends.

Why it matters — VREX watchers would care because this coverage highlights how the company is being evaluated for value-investing potential within Zacks' screening framework.

Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX

Business Wire · 11 Aug 2026negative

Kahn Swick & Foti, LLC (KSF) has announced an investigation into the proposed acquisition of Varex Imaging by Teledyne Technologies, under which Varex shareholders would receive $18.90 in cash per share. KSF is examining whether this consideration and the transaction process are adequate.

Why it matters — VREX shareholders may be affected by the investigation's findings regarding whether the proposed $18.90-per-share deal consideration is fair and the process was adequate.

Teledyne: Varex Acquisition Strengthens The Buy Case

Seeking Alpha · 11 Aug 2026neutral

Teledyne Technologies agreed to acquire Varex Imaging for $1.1 billion, or $18.90 per share, broadening Teledyne's healthcare equipment portfolio and X-ray capabilities.

Why it matters — Varex shareholders will receive $18.90 per share in the acquisition, marking the company's exit as an independent entity.

FAQ

Frequently asked questions about VREX stock

What is the VREX stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Varex Imaging Corp. have a median 12-month price target of $19, with estimates ranging from $19 to $19. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is VREX stock a buy right now?

Of the 3 analysts covering Varex Imaging Corp., 0 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Varex Imaging Corp. 80 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank VREX?

As at 12 Sept 2026, Varex Imaging Corp. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (96 of 100).

Will VREX stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +2.4% from the last close, and Ticker Nerd's factor model ranks Varex Imaging Corp. 80 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the VREX stock forecast for 2030?

No analyst covering Varex Imaging Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VREX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $19 to $19 over the next 12 months.

How has VREX stock performed over the past year?

Varex Imaging Corp. returned +60.5% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Varex Imaging Corp. do?

Varex Imaging Corp. is a medical technology company that designs, manufactures, sells, and services X-ray imaging components and related systems.

What is the latest news on VREX?

The most recent item we track (Business Wire, 12 Sept 2026): "VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders". Halper Sadeh LLC, an investor rights law firm, announced it is investigating whether Varex Imaging Corporation obtained a fair price for its shareholders in its sale to Teledyne Technologies for $18.90 per share in cash. The firm is encouraging Varex shareholders to learn about their rights and options regarding the transaction.

Company

About Varex Imaging Corp.

Varex Imaging Corp. is a medical technology company that designs, manufactures, sells, and services X-ray imaging components and related systems. Varex Imaging Corp. serves two main business segments: Medical and Industrial. Its Medical segment supplies X-ray tubes, digital detectors, high-voltage connectors, image-processing software, workstations, and other components used in applications such as computed tomography, mammography, oncology, and general diagnostic imaging. Its Industrial segment provides X-ray accelerators, detectors, and inspection solutions for security screening, cargo inspection, and non-destructive testing. The company works primarily with original equipment manufacturers, independent service providers, distributors, and end users that integrate its products into imaging platforms. Headquartered in Salt Lake City, Utah, Varex Imaging Corp. plays a specialized role in the global imaging supply chain by providing critical technologies used to detect, diagnose, protect, and inspect across medical, industrial, and security markets.

CEO Mr. Sunny S. Sanyal · 2,500 employees · United States · https://www.vareximaging.com